fluorodeoxyglucose f18 has been researched along with Neoplasms, Cystic, Mucinous, and Serous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doki, Y; Eguchi, H; Kim, T; Kitagawa, T; Kobayashi, S; Marubashi, S; Mori, M; Nagano, H; Takeda, Y; Tanemura, M; Tatsumi, M; Tomimaru, Y; Umeshita, K; Wakasa, K | 1 |
| Cho, A; Choi, JY; Choi, YJ; Hong, HS; Kim, KW; Kim, MJ; Lee, JD; Yun, M | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and Neoplasms, Cystic, Mucinous, and Serous
| Article | Year |
|---|---|
Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary-mucinous neoplasm of the pancreas.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Carcinoma in Situ; Carcinoma, Pancreatic Ductal; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Japan; Male; Middle Aged; Neoplasms, Cystic, Mucinous, and Serous; Pancreatectomy; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
The utility of F-18 FDG PET/CT in the evaluation of pancreatic intraductal papillary mucinous neoplasm.
Topics: Aged; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Cystic, Mucinous, and Serous; Pancreatic Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2010 |